首页> 外文期刊>European journal of human genetics: EJHG >No evidence for pathogenic variants or maternal effect of ZFP57 as the cause of Beckwith-Wiedemann Syndrome.
【24h】

No evidence for pathogenic variants or maternal effect of ZFP57 as the cause of Beckwith-Wiedemann Syndrome.

机译:没有证据表明ZFP57是贝克威-韦德曼综合征的病原体或母体作用。

获取原文
获取原文并翻译 | 示例
       

摘要

Beckwith-Wiedemann syndrome (BWS) is an overgrowth syndrome, which, in 50-60% of sporadic cases, is caused by hypomethylation of KCNQ1OT1 differentially methylated region (DMR) at chromosome 11p15.5. The underlying defect of this hypomethylation is largely unknown. Recently, recessive mutations of the ZFP57 gene were reported in patients with transient neonatal diabetes mellitus type 1, showing hypomethylation at multiple imprinted loci, including KCNQ1OT1 DMR in some. The aim of our study was to determine whether ZFP57 alterations were a genetic cause of the hypomethylation at KCNQ1OT1 DMR in patients with BWS. We sequenced ZFP57 in 27 BWS probands and in 23 available mothers to test for a maternal effect. We identified three novel, presumably benign sequence variants in ZFP57; thus, we found no evidence for ZFP57 alterations as a major cause in sporadic BWS cases.
机译:Beckwith-Wiedemann综合征(BWS)是一种过度生长综合征,在50-60%的散发病例中,是由KCNQ1OT1甲基化区域11p15.5处的甲基化过低引起的。这种低甲基化的潜在缺陷在很大程度上是未知的。最近,在患有短暂性新生儿1型糖尿病的患者中报道了ZFP57基因的隐性突变,显示在多个印迹基因座(包括KCNQ1OT1 DMR)中出现甲基化不足。我们研究的目的是确定ZFP57改变是否是BWS患者KCNQ1OT1 DMR低甲基化的遗传原因。我们在27名BWS先证者和23名可用母亲中对ZFP57进行了测序,以测试其母性效应。我们在ZFP57中鉴定了三个新颖的,大概是良性的序列变体。因此,我们没有发现ZFP57改变是散发性BWS病例的主要原因的证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号